Evidence map›Paper›PMID 37598707›Full record

ArticlePhilosophical transactions of the Royal Society of London. Series B, Biological sciences2023

A modelling analysis of a new multi-stage pathway for classifying achievement of public health milestones for leprosy.

Emma L Davis, Ron E Crump, Graham F Medley, Anthony W Solomon, Venkata Ranganadha Rao Pemmaraju, T Déirdre Hollingsworth

Abstract read
In one paragraph

Article in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. A modelling analysis of a new multi-stage pathway for classifying achievement of public health milestones for leprosy.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emma L DavisMathematics Institute, University of Warwick, Coventry, CV4 7AL, UK.ORCID 0000-0001-6261-775X
Ron E CrumpMathematics Institute, University of Warwick, Coventry, CV4 7AL, UK.
Graham F MedleyLondon School of Hygiene & Tropical Medicine, London, WC1E 7HT, UK.
Anthony W SolomonGlobal Neglected Tropical Diseases Programme, World Health Organization, Geneva, 1211, Switzerland.
Venkata Ranganadha Rao PemmarajuGlobal Leprosy Programme, World Health Organization, New Delhi, India.
T Déirdre HollingsworthBig Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, OX3 7LF, UK.ORCID 0000-0001-5962-4238

Funding

World Health Organization 001
6 · The paper itself

Abstract

Several countries have come close to eliminating leprosy, but leprosy cases continue to be detected at low levels. Due to the long, highly variable delay from infection to detection, the relationship between observed cases and transmission is uncertain. The World Health Organization's new technical guidance provides a path for countries to reach elimination. We use a simple probabilistic model to simulate the stochastic dynamics of detected cases as transmission declines, and evaluate progress through the new public health milestones. In simulations where transmission is halted, 5 years of zero incidence in autochthonous children, combined with 3 years of zero incidence in all ages is a flawed indicator that transmission has halted (54% correctly classified). A further 10 years of only occasional sporadic cases is associated with a high probability of having interrupted transmission (99%). If, however, transmission continues at extremely low levels, it is possible that cases could be misidentified as historic cases from the tail of the incubation period distribution, although misleadingly achieving all three milestones is unlikely (less than 1% probability across a 15-year period of ongoing low-level transmission). These results demonstrate the feasibility and challenges of a phased progression of milestones towards interruption of transmission, allowing assessment of programme status. This article is part of the theme issue 'Challenges and opportunities in the fight against neglected tropical diseases: a decade from the London Declaration on NTDs'.

Indexed as

LeprosyPublic HealthChildHumansLondonModels, StatisticalNeglected DiseaseseliminationHansen's diseaseinterruption of transmissionleprosymilestonesmodelling

Identifiers

PMID37598707
PMCPMC10440169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.